Now Reading: Kedaara Capital invests $200 million in Tynor Orthotics
-
01
Kedaara Capital invests $200 million in Tynor Orthotics
Kedaara Capital has acquired a majority stake of about 51% in Tynor Orthotics for $200 million, the companies announced. The Mohali-based firm makes orthopaedic supports, mobility aids and rehabilitation products. Mint first reported in January that Kedaara was the front-runner for a majority stake at a valuation of about Rs 3,500-4,000 crore. Existing investor Lighthouse Funds and promoters were expected to sell a combined 60% stake.
Tynor's products reach over 300,000 retail outlets and 8,000 hospitals across 60 countries and have served more than 100 million people. The company operates three manufacturing facilities. Kedaara will work with promoters P.J. Singh and A.J. Singh, management, and French strategic partner Thuasne to build an ortho-focused wellness platform. Tynor aims to become a leader in the global south and a key supply chain partner for the global north, according to its promoters.
Indian Opinion Analysis
All three sources report the deal as a straightforward business investment, using the same company statements and executive quotes. The Economic Times specifies the stake as "about 51%", while Mint mentions the earlier valuation estimate of Rs 3,500-4,000 crore and the sellers' expected 60% stake. No source adopts a critical or political framing. The coverage is uniform straight reporting. The transaction shows continued private equity confidence in India's medical devices sector, which Kedaara calls one of the fastest-growing globally. O3 Capital was the exclusive financial advisor.
Coverage: 3 sources, 3 neutral
Sources (3): livemint.com (neutral report), economictimes.indiatimes.com (neutral report), health.economictimes.indiatimes.com (neutral report)
This brief was synthesised by AI from the 3 sources linked above, so one read covers every framing they carry. Methodology and corrections.
Updated: this story now draws on 3 sources.
